Human equilibrative nucleoside transporter‐1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S‐1 chemotherapy

The high expression of human equilibrative nucleoside transporter‐1 (hENT1) and the low expression of dihydropyrimidine dehydrogenase (DPD) are reported to predict a favorable prognosis in patients treated with gemcitabine (GEM) and 5‐fluorouracil (5FU) as the adjuvant setting, respectively. The exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Yukiyasu, Yasukawa, Satoru, Narimatsu, Hiroto, Boku, Narikazu, Fukutomi, Akira, Konishi, Masaru, Morinaga, Soichiro, Toyama, Hirochika, Kaneoka, Yuji, Shimizu, Yasuhiro, Nakamori, Shoji, Sata, Naohiro, Yamakita, Keisuke, Takahashi, Amane, Kainuma, Osamu, Hishinuma, Shoichi, Yamaguchi, Ryuzo, Nagino, Masato, Hirano, Satoshi, Yanagisawa, Akio, Mori, Keita, Uesaka, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004513/
https://www.ncbi.nlm.nih.gov/pubmed/31778273
http://dx.doi.org/10.1111/cas.14258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004513/
https://www.ncbi.nlm.nih.gov/pubmed/31778273
http://dx.doi.org/10.1111/cas.14258

Ejemplares similares